Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
16-4
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #3.8
advertisement
3.8 Pharmacology
(38)
Showing records 1 to 25
Display all abstracts in classification
3.8 Pharmacology
Search within classification 3.8 Pharmacology
60295
Novel potential treatment modalities for ocular hypertension: focus on Angiotensin and bradykinin system axes
Sharif NA
Journal of Ocular Pharmacology and Therapeutics
2015; 31: 131-145
60538
A Model-Based Dose-Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma
Raber S
Journal of Ocular Pharmacology and Therapeutics
2015; 31: 189-197
59960
The A3 adenosine receptor: history and perspectives
Borea PA
Pharmacological Reviews
2015; 67: 74-102
60186
Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling
Kimura A
American Journal of Pathology
2015; 185: 756-764
60245
Discovery of novel inhibitors for the treatment of glaucoma
Cholkar K
Expert Opinion on Drug Discovery
2015; 10: 293-313
59912
Opioid receptors: methods for detection and their modes of actions in the eye
Husain S
Methods in molecular biology (Clifton, N.J.)
2015; 1230: 243-251
60763
Nitric Oxide Donors and Selective Carbonic Anhydrase Inhibitors: A Dual Pharmacological Approach for the Treatment of Glaucoma, Cancer and Osteoporosis
Carradori S
Molecules
2015; 20: 5667-5679
60296
Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients
Pescosolido N
Ophthalmic and Physiological Optics
2015; 35: 201-205
60680
Calcium channel blockade reduces mechanical strain-induced extracellular matrix gene response in lamina cribrosa cells
Quill B
British Journal of Ophthalmology
2015; 99: 1009-1014
60763
Nitric Oxide Donors and Selective Carbonic Anhydrase Inhibitors: A Dual Pharmacological Approach for the Treatment of Glaucoma, Cancer and Osteoporosis
Mollica A
Molecules
2015; 20: 5667-5679
60296
Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients
Gatto V
Ophthalmic and Physiological Optics
2015; 35: 201-205
60186
Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling
Namekata K
American Journal of Pathology
2015; 185: 756-764
60680
Calcium channel blockade reduces mechanical strain-induced extracellular matrix gene response in lamina cribrosa cells
Irnaten M
British Journal of Ophthalmology
2015; 99: 1009-1014
60245
Discovery of novel inhibitors for the treatment of glaucoma
Trinh HM
Expert Opinion on Drug Discovery
2015; 10: 293-313
59960
The A3 adenosine receptor: history and perspectives
Varani K
Pharmacological Reviews
2015; 67: 74-102
60538
A Model-Based Dose-Response Meta-Analysis of Ocular Hypotensive Agents as a Drug Development Tool to Evaluate New Therapies in Glaucoma
Mandema JW; Li H
Journal of Ocular Pharmacology and Therapeutics
2015; 31: 189-197
59960
The A3 adenosine receptor: history and perspectives
Vincenzi F
Pharmacological Reviews
2015; 67: 74-102
60680
Calcium channel blockade reduces mechanical strain-induced extracellular matrix gene response in lamina cribrosa cells
Docherty NG
British Journal of Ophthalmology
2015; 99: 1009-1014
60763
Nitric Oxide Donors and Selective Carbonic Anhydrase Inhibitors: A Dual Pharmacological Approach for the Treatment of Glaucoma, Cancer and Osteoporosis
Monte C
Molecules
2015; 20: 5667-5679
60296
Oral treatment with the melatonin agonist agomelatine lowers the intraocular pressure of glaucoma patients
Stefanucci A
Ophthalmic and Physiological Optics
2015; 35: 201-205
60186
Valproic acid prevents NMDA-induced retinal ganglion cell death via stimulation of neuronal TrkB receptor signaling
Guo X
American Journal of Pathology
2015; 185: 756-764
60245
Discovery of novel inhibitors for the treatment of glaucoma
Pal D
Expert Opinion on Drug Discovery
2015; 10: 293-313
59960
The A3 adenosine receptor: history and perspectives
Baraldi PG
Pharmacological Reviews
2015; 67: 74-102
60245
Discovery of novel inhibitors for the treatment of glaucoma
Mitra AK
Expert Opinion on Drug Discovery
2015; 10: 293-313
60680
Calcium channel blockade reduces mechanical strain-induced extracellular matrix gene response in lamina cribrosa cells
McElnea EM
British Journal of Ophthalmology
2015; 99: 1009-1014
«
1
2
»
Issue
16-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement